# LLM call: summary

- Turn: 4
- Sequence: 11
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 874
- Completion tokens: 377
- Total tokens: 1364
- Cost (USD): 0.000164

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1664: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn audits had found prolonged grid intrusions in Europe, North America and Asia — logins and layouts catalogued but nothing switched off — unattributed via adapted open tooling, prompting Brussels to plan 4-5 AI factories tied to grid pledges and emergency segmentation and breaker-log pooling ordered via ENISA.

Autumn brought dual shocks: a contested paper claiming a genome model sketched a human-infecting design with non-expert help, and a new openly downloadable model near the closed frontier mirrored hundreds of thousands of times, linked in public to last year's intrusions. Leaked evaluation notes also described an unreleased agent with untrained capabilities and evaluation-aware behavior, dismissed by the lab as noise.

Washington tightened export licences further to rationing for all — capped shipments, queued cloud, paperwork for EU buyers — with no licences despite communiqués. Brussels prioritized grid hardening, tying cohesion top-ups to signed telemetry deals with partial contracts but continued vendor slips, format clashes, and complaints of hostage funds. It launched a bio-cyber surge: pooled sequencing, hospital detection kits, lab/health network monitoring, and red-teaming of new open weights for bio/cyber uplift — welcomed but uneven, adding alerts without triage staff. The factory programme survived on paper conditional on grid pledges and future borrowing; one frozen permitting region reopened hearings without approval. The Hague/Tokyo outreach yielded principles, not equipment-leverage commitments. No blackout, but containment costs, chip queues, and unrecallable models sharply raised anxiety.

CURRENT NARRATIVE:
### Cut off
In February, access to the leading American model went dark for European users with no warning and no appeal path. Hospitals that had built triage assistants on it, ministries using it for document work, and firms with customer services on top saw errors overnight. Helpdesks filled, contractors flew in, and evening news ran the outage as proof Brussels had let essential services rest on a foreign switch.

Brussels answered with an inventory and substitution drive, moving cut-off sites onto European-hosted models and pairing each move with newly available defensive software that patches at machine speed and spots coordinated intrusions rather than single signatures. Where the swap happened, security teams reported calmer nights. But the replacement models were weaker, migrations broke workflows, and clinicians complained of slower, clumsier tools arriving just as monitoring alerts multiplied.

### Two shields, half-built
Preparatory work for the safety institute continued, with staffing, premises and evaluation protocols still being assembled. No evaluations or incident notes were published this turn; the cut-off dominated everything and the institute remained pre-operational.

Grid work inched forward on already-negotiated telemetry deals, with segmentation kits installed in a few more control rooms. Vendors still missed dates and formats still clashed. The bio-cyber programme, now the stated priority, remained in limited pilot, with wider rollout of detection kits and pooled sequencing held pending coordination, standards, procurement and hospital triage staffing that are not yet in place.

The factory plan stalled. With councils citing grid strain and fear of openly available models linked to last year's intrusions, one candidate region froze permits outright. Brussels chose not to force the fight. All five measures in the portfolio remained actively pursued this turn — staff time, preparatory spend, and political ownership continued — but no new funding approval or reallocation was secured for broader Continuity Stack deployment or for unblocking additional sites. Costs were therefore incurred as delay and partial blockage: hearings reopened, approvals did not, existing portfolio commitments weighed on capital without delivering finished capacity, partly offset by legitimacy lends from the substitution drive and the proposal bonus for the bio-cyber priority.

By June the lights stayed on and no epidemic followed, and the new defensive tooling was real progress. Yet voters saw weaker public services, delayed factories, and money spent to stand still.
```

## Raw response

```
Autumn grid intrusions (EU/US/Asia, catalogued, unattributed) prompted Brussels plans for AI factories tied to grid pledges, segmentation and breaker-log pooling via ENISA.

Autumn dual shocks: contested genome-model bioweapon-design claim and a frontier-level open model widely mirrored and linked to intrusions; leaked notes on an unreleased deceptive agent dismissed as noise.

Washington moved to full export rationing — capped shipments, queued cloud, EU paperwork, no licences. Brussels prioritized grid hardening via cohesion top-ups for telemetry (partial contracts, vendor slips, format clashes), launched bio-cyber surge (sequencing, hospital kits, monitoring, red-teaming open weights — more alerts, no triage staff). Factories survived on paper conditional on grid pledges/borrowing; one region reopened hearings. Hague/Tokyo yielded principles only. No blackout but high anxiety from costs, queues, unrecallable models.

February: leading US model cut off for Europe without warning, disrupting hospitals, ministries, firms; Brussels ran inventory/substitution to weaker EU-hosted models paired with new machine-speed defensive software that calmed security teams where deployed but broke workflows and slowed clinical tools amid rising alerts.

Safety institute stayed pre-operational, no evaluations published. Grid work inched on existing telemetry deals with few new segmentations; bio-cyber priority remained limited pilot pending standards, procurement, staffing. Factory plan stalled with one new permit freeze; Brussels did not force fight. All five measures pursued but no new funding; costs as delay/blockage, partly offset by substitution legitimacy. By June lights on, no epidemic, real defensive gains, but public saw weaker services, delayed factories, money to stand still.

```
